Next Article in Journal
Induction of Heat Shock Protein 70 Ameliorates Ultraviolet-Induced Photokeratitis in Mice
Next Article in Special Issue
HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series
Previous Article in Journal
Low Oxygen Tension Maintains Multipotency, Whereas Normoxia Increases Differentiation of Mouse Bone Marrow Stromal Cells
Previous Article in Special Issue
Metabolic Profiles of Brain Metastases
Int. J. Mol. Sci. 2013, 14(1), 2135-2174; doi:10.3390/ijms14012135
Review

Innovative Therapeutic Strategies in the Treatment of Brain Metastases

1
, 2
, 1,* , 1
, 1
, 1
, 1
 and 1
Received: 9 December 2012; in revised form: 8 January 2013 / Accepted: 9 January 2013 / Published: 22 January 2013
(This article belongs to the Special Issue Brain Metastasis)
View Full-Text   |   Download PDF [310 KB, uploaded 19 June 2014]
Abstract: Brain metastases (BM) are the most common intracranial tumors and their incidence is increasing. Untreated brain metastases are associated with a poor prognosis and a poor performance status. Metastasis development involves the migration of a cancer cell from the bulk tumor into the surrounding tissue, extravasation from the blood into tissue elsewhere in the body, and formation of a secondary tumor. In the recent past, important results have been obtained in the management of patients affected by BM, using surgery, radiation therapy, or both. Conventional chemotherapies have generally produced disappointing results, possibly due to their limited ability to penetrate the blood–brain barrier. The advent of new technologies has led to the discovery of novel molecules and pathways that have better depicted the metastatic process. Targeted therapies such as bevacizumab, erlotinib, gefitinib, sunitinib and sorafenib, are all licensed and have demonstrated improved survival in patients with metastatic disease. In this review, we will report current data on targeted therapies. A brief review about brain metastatic process will be also presented.
Keywords: angiogenesis; blood–brain barrier; brain metastases; cancer stem cells; microRNA; targeted therapy angiogenesis; blood–brain barrier; brain metastases; cancer stem cells; microRNA; targeted therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Caffo, M.; Barresi, V.; Caruso, G.; Cutugno, M.; La Fata, G.; Venza, M.; Alafaci, C.; Tomasello, F. Innovative Therapeutic Strategies in the Treatment of Brain Metastases. Int. J. Mol. Sci. 2013, 14, 2135-2174.

AMA Style

Caffo M, Barresi V, Caruso G, Cutugno M, La Fata G, Venza M, Alafaci C, Tomasello F. Innovative Therapeutic Strategies in the Treatment of Brain Metastases. International Journal of Molecular Sciences. 2013; 14(1):2135-2174.

Chicago/Turabian Style

Caffo, Maria; Barresi, Valeria; Caruso, Gerardo; Cutugno, Mariano; La Fata, Giuseppe; Venza, Mario; Alafaci, Concetta; Tomasello, Francesco. 2013. "Innovative Therapeutic Strategies in the Treatment of Brain Metastases." Int. J. Mol. Sci. 14, no. 1: 2135-2174.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert